SCHEMBL374372

SCHEMBL374372

C[C](C)C(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3399645 0.74 ALDH1A1 (0.46)
SCHEMBL3399641 0.74 ALDH1A1 (0.46)
SCHEMBL39387 0.74
SCHEMBL490224 0.71
SCHEMBL2877 0.71
SCHEMBL2546600 0.70
SCHEMBL42054 0.70
SCHEMBL73997 0.70
SCHEMBL17236155 0.70
SCHEMBL74607 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210330678-A1 PAPD5 INHIBITORS AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-10-28 US claimed
EP-3897644-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF Revolution Medicines, Inc. (US) 2021-10-27 EP claimed
CN-113498342-A Compounds involved in synergistic binding and uses thereof 锐新医药公司 2021-10-12 CN claimed
EP-3846808-A2 PAPD5 INHIBITORS AND METHODS OF USE THEREOF CHILDREN'S MEDICAL CENTER CORPORATION (US) 2021-07-14 EP claimed
US-20200197391-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF Revolution Medicines, Inc. 2020-06-25 US claimed
WO-2020132597-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF Revolution Medicines, Inc. (US) 2020-06-25 WO claimed
EP-3256471-B1 NOVEL 2-OXO-6,7-DIHYDROBENZO[A]QUINOLIZINE-3-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2018-12-12 EP claimed
US-10093671-B2 2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection HOFFMANN-LA ROCHE INC. (US) 2018-10-09 US claimed
CN-108026432-A Selective nitride slurry with improved stability and improved polishing characteristic 嘉柏微电子材料股份公司 2018-05-11 CN claimed
US-9949966-B2 Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection HOFFMAN-LA ROCHE INC. (US) 2018-04-24 US claimed
US-5696194-A CONTAINS ACRYLAMIDE, N-ALKYLACRYLAMIDE AND N,N-DIALKYLACRYLAMIDE; QUATERNIZATION BETZDEARBORN INC. (US) 1997-12-09 US claimed
EP-0637598-B1 Hydrophobic dispersants used in forming polymer dispersions NALCO CHEMICAL CO (US) 1997-05-02 EP claimed
US-5614602-A ADDITION POLYMERIZATION OF CATIONIC MONOMERS, USED TO DEWATER SLUDGE AND IN PAPER RETENTION BETZDEARBORN INC. (US) 1997-03-25 US claimed
US-5597858-A POLYMERIZATION OF CATIONIC MONOMERS AS DISPERSANTS NALCO CHEMICAL COMPANY (US) 1997-01-28 US claimed
US-5597859-A FORMING DIALKYLAMINOALKYL(METH)ACYLAMIDE POLYMER DISPERSIONS NALCO CHEMICAL COMPANY (US) 1997-01-28 US claimed
US-5466338-A ADDING A WATER SOLUBLE CATIONIC POLYMER TO A REPULPED BROKE SLURRY NALCO CHEMICAL COMPANY (US) 1995-11-14 US claimed
EP-0657478-A2 An improved process for the preparation of water soluble polymer dispersion NALCO CHEMICAL COMPANY (US) 1995-06-14 EP claimed
EP-0637598-A2 Hydrophobic dispersants used in forming polymer dispersions NALCO CHEMICAL COMPANY (US) 1995-02-08 EP claimed
EP-0385630-A2 1H-imidazo(4,5-c)Quinolin-4-amines as antivirals RIKER LABORATORIES, INC. (US) 1990-09-05 EP claimed
US-4792644-A ZEOLITE AND QUATERNARY AMMONIUM SALT TOSOH CORPORATION (JP) 1988-12-20 US claimed